02:13:45 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-07 Bokslutskommuniké 2024
2024-10-23 Kvartalsrapport 2024-Q3
2024-07-18 Kvartalsrapport 2024-Q2
2024-05-16 X-dag ordinarie utdelning CRAD B 0.00 SEK
2024-05-15 Årsstämma 2024
2024-05-14 Kvartalsrapport 2024-Q1
2024-02-08 Bokslutskommuniké 2023
2023-10-27 Kvartalsrapport 2023-Q3
2023-07-20 Kvartalsrapport 2023-Q2
2023-05-08 X-dag ordinarie utdelning CRAD B 0.00 SEK
2023-05-05 Kvartalsrapport 2023-Q1
2023-05-05 Årsstämma 2023
2023-01-26 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-07-21 Kvartalsrapport 2022-Q2
2022-05-09 X-dag ordinarie utdelning CRAD B 0.00 SEK
2022-05-06 Årsstämma 2022
2022-05-06 Kvartalsrapport 2022-Q1
2022-01-27 Bokslutskommuniké 2021
2021-10-28 Kvartalsrapport 2021-Q3
2021-07-29 Kvartalsrapport 2021-Q2
2021-05-10 X-dag ordinarie utdelning CRAD B 0.00 SEK
2021-05-07 Årsstämma 2021
2021-05-07 Kvartalsrapport 2021-Q1
2021-01-28 Bokslutskommuniké 2020
2020-10-22 Kvartalsrapport 2020-Q3
2020-07-31 Kvartalsrapport 2020-Q2
2020-05-11 X-dag ordinarie utdelning CRAD B 0.00 SEK
2020-05-08 Årsstämma 2020
2020-05-06 Kvartalsrapport 2020-Q1
2020-01-31 Bokslutskommuniké 2019
2019-12-17 Extra Bolagsstämma 2019
2019-10-25 Kvartalsrapport 2019-Q3
2019-08-30 Kvartalsrapport 2019-Q2
2019-05-09 X-dag ordinarie utdelning CRAD B 0.00 SEK
2019-05-08 Årsstämma 2019
2019-05-08 Kvartalsrapport 2019-Q1
2019-02-08 Bokslutskommuniké 2018
2018-10-26 Kvartalsrapport 2018-Q3
2018-08-17 Kvartalsrapport 2018-Q2
2018-05-31 Årsstämma 2018
2018-05-18 X-dag ordinarie utdelning CRAD B 0.00 SEK
2018-04-26 Kvartalsrapport 2018-Q1
2018-01-31 Bokslutskommuniké 2017
2017-10-27 Kvartalsrapport 2017-Q3
2017-08-16 Kvartalsrapport 2017-Q2
2017-05-02 X-dag ordinarie utdelning CRAD B 0.00 SEK
2017-04-28 Kvartalsrapport 2017-Q1
2017-04-28 Årsstämma 2017
2017-02-13 Bokslutskommuniké 2016
2016-11-17 Extra Bolagsstämma 2016
2016-11-14 Kvartalsrapport 2016-Q3
2016-08-24 Kvartalsrapport 2016-Q2
2016-05-09 Kvartalsrapport 2016-Q1
2016-04-15 X-dag ordinarie utdelning CRAD B 0.00 SEK
2016-04-14 Årsstämma 2016
2016-02-08 Bokslutskommuniké 2015
2015-11-06 Kvartalsrapport 2015-Q3
2015-08-14 Kvartalsrapport 2015-Q2
2015-05-08 Kvartalsrapport 2015-Q1
2015-04-17 X-dag ordinarie utdelning CRAD B 0.00 SEK
2015-04-16 Årsstämma 2015
2015-01-30 Bokslutskommuniké 2014
2014-11-07 Analytiker möte 2014
2014-11-07 Kvartalsrapport 2014-Q3
2014-08-15 Kvartalsrapport 2014-Q2
2014-05-16 Kvartalsrapport 2014-Q1
2014-04-17 X-dag ordinarie utdelning CRAD B 0.00 SEK
2014-04-16 Årsstämma 2014
2014-02-17 Bokslutskommuniké 2013
2013-11-28 Kvartalsrapport 2013-Q3
2013-11-01 Analytiker möte 2013
2013-10-30 Extra Bolagsstämma 2013
2013-09-02 15-7 2013
2013-08-30 Kvartalsrapport 2013-Q2
2013-06-03 X-dag ordinarie utdelning CRAD B 0.00 SEK
2013-05-31 Årsstämma 2013
2013-05-29 Kvartalsrapport 2013-Q1
2013-02-26 Bokslutskommuniké 2012
2012-12-04 Extra Bolagsstämma 2012
2012-11-28 Kvartalsrapport 2012-Q3
2012-09-04 Kvartalsrapport 2012-Q2
2012-06-04 X-dag ordinarie utdelning CRAD B 0.00 SEK
2012-06-01 Årsstämma 2012
2012-05-24 Kvartalsrapport 2012-Q1
2012-02-24 Bokslutskommuniké 2011
2011-11-25 Kvartalsrapport 2011-Q3
2011-08-26 Kvartalsrapport 2011-Q2
2011-05-26 X-dag ordinarie utdelning CRAD B 0.00 SEK
2011-05-25 Årsstämma 2011
2011-05-24 Kvartalsrapport 2011-Q1
2011-02-11 Bokslutskommuniké 2010
2010-06-02 X-dag ordinarie utdelning CRAD B 0.00 SEK
2010-06-01 Årsstämma 2010
2010-05-28 Kvartalsrapport 2010-Q1
2009-11-27 Kvartalsrapport 2009-Q3

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
C-Rad är verksamma inom medicinteknik. Bolaget bedriver utveckling, tillverkning och försäljning av produkter och lösningar inom avancerad strålterapi. Verksamheten riktar sig huvudsakligen mot kliniker som erbjuder strålbehandling, där bolaget utöver kärnverksamheten erbjuder tillhörande installationstjänster och support. Kunderna återfinns på global nivå och huvudkontoret ligger i Uppsala.
2022-02-24 13:00:00

Leben Salud, a prestigious medical institution located in the Argentine Patagonia, becomes the first clinic in Latin America to incorporate C-RAD technology to enable safer radiation treatment to more patients and help improve their quality of life.

“At Leben Salud the patients safety and comfort is our highest priority. We selected the C-RAD Catalyst+HD system to enable us to provide this new treatment technology with the highest level of accuracy and safety possible Says Ricardo Ruggeri, Ms. C. en Física Médica, Dirección Técnica de Leben Salud sd – “ With this state-of-the-art system we will know we are offering the best quality of care for our patients.
 
The collaboration between C-RAD and the Comprehensive Cancer Center (COI) includes the implementation of C-RAD Catalyst+ HD and Sentinel (4DCT) in its Neuquén facilities, and the implementation of Catalyst+ HD in its Cipolletti facilities.
 
We are delighted to initiate this collaboration with Leben Salud and to team up with them to pioneer the development of surface tracking technology once again and making it standard of care in Patagonia, says Tim Thurn, CEO of C-RAD AB. 
 
C-RAD Catalyst+ HD SGRT technology uses multiple high-resolution projection cameras to map the patient's body surface during setup and treatment. This high-resolution surface map improves treatment accuracy, treatment efficacy, and patient safety. Unlike other positioning technologies, SGRT does not use radiation for positioning, reducing the patient's overall radiation exposure.
 
“SGRT uses the external surface of the patient to help ensure that the radiation dose is delivered consistently according to the treatment plan”, explains Douglas Utter, Latin America Sales Director of C-RAD.
 
“The Catalyst+ HD system provides sub-millimeter accuracy for stereotactic body radiation therapy (SBRT) as well as deep inspiration breath hold treatments (DIBH). The DIBH technique is used for breast cancer treatments and we are very proud to be one of the first clinics in Patagonia to be able to offer this type of treatments for our patients.” Continues Ricardo Ruggeri, Ms. C. en Física Médica, Dirección Técnica de Leben Salud sd “Overall, the C-RAD SGRT systems will be a valuable tool to improve the accuracy of radiotherapy in Patagonia”.

About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD (Shanghai) Medical Devices Co Ltd. In China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm. For more information on C-RAD, please visit http://www.c-rad.com.
 
For further information about C-RAD AB:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com
 
About Leben Salud
Leben Salud is an institution in which more than 1,000 people work, in 6 locations (in the provinces of Río Negro and Neuquén, both of which are part of Argentine Patagonia).
Of the 1,000 workers, we have doctors, administrative staff, nurses, technicians, and auxiliary personnel. The contribution of each one is exceptional.
Leben provides diagnosis, treatment and rehabilitation services to more than 30,000 patients per month, with a great commitment to society and our people.
As a necessary condition for development and sustainability, Leben Salud promotes the training of clinical cardiologists, cardiovascular surgeons, hemodynamicists, cardiovascular imaging specialists and medical physicists for the oncology area, through formal residency systems, preparing a staff that is projected for the next 20 years focused on the fields of knowledge, development and research in these areas.
There is a long way to go that is not exhausted at present, and they are convinced of offering the entire population of the Patagonian region the latest technological advances in the fight against cancer, cardiovascular disease and the highly complex diagnosis by images.
As an institution, they understand that this is one of the most ambitious challenges, but that it has a real impact on the health of the Region, since their commitment to patients, their work culture, and their cutting-edge technology make this action possible.
Leben Salud also has the purpose of shortening distances and bringing people closer to the assistance that their health needs.
 
For further information about Leben Salud:
E-mail: info@lebensalud.com